0001666071-21-000148.txt : 20210716 0001666071-21-000148.hdr.sgml : 20210716 20210716165047 ACCESSION NUMBER: 0001666071-21-000148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210714 FILED AS OF DATE: 20210716 DATE AS OF CHANGE: 20210716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laube Lynne Marie CENTRAL INDEX KEY: 0001730687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 211095959 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_162646861487045.xml FORM 4 X0306 4 2021-07-14 0 0001666071 Cardlytics, Inc. CDLX 0001730687 Laube Lynne Marie C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 1 1 0 0 Chief Executive Officer Common Stock 2021-07-14 4 M 0 3376 20 A 311708 D Common Stock 2021-07-14 4 S 0 1976 123.77 D 309732 D Common Stock 2021-07-14 4 S 0 1100 124.56 D 308632 D Common Stock 2021-07-14 4 S 0 300 125.77 D 308332 D Common Stock 2021-07-15 4 M 0 2138 20 A 310470 D Common Stock 2021-07-15 4 S 0 300 120.42 D 310170 D Common Stock 2021-07-15 4 S 0 400 122.29 D 309770 D Common Stock 2021-07-15 4 S 0 638 123.03 D 309132 D Common Stock 2021-07-15 4 S 0 700 124.95 D 308432 D Common Stock 2021-07-15 4 S 0 100 125.56 D 308332 D Common Stock 14565 I See Footnote Common Stock 14565 I See Footnote Employee Stock Option (Right to Buy) 20.0 2021-07-14 4 M 0 3376 0 D 2026-08-02 Common Stock 3376.0 44025 D Employee Stock Option (Right to Buy) 20.0 2021-07-15 4 M 0 2138 0 D 2026-08-02 Common Stock 2138.0 41887 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $123.14 to $124.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.15 to $124.895, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.70 to $125.90, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $120.07 to $120.66, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.725 to $122.64, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $122.80 to $123.23, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.47 to $125.30, inclusive. The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright. The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright. Fully vested. /s/ Kirk Somers, Attorney-in-Fact 2021-07-16